May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
-Secretase Regulates Vascular Permeability Through the Association of VEGFR-1 With VE-Cadherin and ß-Catenin in Response to PEDF
Author Affiliations & Notes
  • M. E. Boulton
    Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas
  • J. Cai
    Ophthalmology and Visual Sciences, University of Texas Medical Branch, Galveston, Texas
  • S. Caballero
    Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida
  • M. B. Grant
    Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida
  • Footnotes
    Commercial Relationships M.E. Boulton, None; J. Cai, None; S. Caballero, None; M.B. Grant, None.
  • Footnotes
    Support Wellcome Trust
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1734. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. E. Boulton, J. Cai, S. Caballero, M. B. Grant; -Secretase Regulates Vascular Permeability Through the Association of VEGFR-1 With VE-Cadherin and ß-Catenin in Response to PEDF. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1734. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: We have previously shown that γ-secretase mediates the intramembranous proteolysis of VEGFR-1 (Cai et al. J Biol Chem. 2006). Since VEGFR-1 is associated with adherens junctions, we hypothesized that translocated VEGFR-1 can associate with the VE-cadherin complex to regulate vascular permeability.

Methods:: Primary bovine retinal microvascular endothelial cells were prepared and treated with VEGFA (100ng/ml), PEDF (100ng/ml) and/or γ-secretase inhibitor (12.5 nM) for up to 24 hours. Total cell lysates were immunoprecipitated with an antibody against the C-terminus of VEGFR-1, and subsequent Western blots were probed with antibodies against adherens junction proteins (α-, ß-catenin, VE-cadherin) and two major components of the γ-secretase complex (presenilin-1 and nicastrin). Transendothelial resistance was measured in cells exposed to growth factors in the presence and absence of γ-secretase inhibitor. In addition, in vivo vascular permeability in the oxygen-induced retinopathy (OIR) model was assessed following modulation of γ-secretase activity.

Results:: Western blotting demonstrated constitutive association between VEGFR-1, α-catenin, ß-catenin and VE-cadherin in confluent microvascular endothelial cells. The addition of PEDF upregulated γ-secretase activity, blocked VEGF-induced permeability and decreased VEGF-induced-association of VEGFR-1 with ß-catenin and VE-cadherin. Addition of γ-secretase inhibitor abolished the response to PEDF. In the OIR model PEDF-modulated upregulation of γ-secretase reduced vascular permeability and this was partially reduced following intravitreal injection of γ-secretase inhibitor. The translocation of VEGFR-1 to the adherens junction was dependent on the association of presenilin and nicastrin with membrane bound VEGFR-1. Translocation of VEGFR-1 and changes in vascular permeability was blocked when presenilin-1 and nicastrin were prevented from binding to VEGFR-1.

Conclusions:: γ-secretase regulates vascular endothelial permeability by modulating VEGFR1 association with the VE-cadherin, ß-catenin complex.

Keywords: growth factors/growth factor receptors • signal transduction • cell adhesions/cell junctions 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×